AELIS FARMA’s Post

SFBN Feed: BridgeBio gathers investors to launch rare disease-focused spinoff https://lnkd.in/gQEigHGr The company earlier this year spun out a cancer-focused company with $200 million. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News

Worth to follow these webinar. Great value.

SFBN Feed: How fish inspired a biotech company to extend the life of transplant organs, cells https://lnkd.in/gjbvrjHs Ex-Therma counts among its investors Jim Greenwood, the former CEO of the Biotechnology Innovation Organization. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News

Bud-wiser: DOD Backs A-Alpha Bio for Biothreat Preparation https://lnkd.in/gwVD-TNM A-Alpha Bio, a Seattle-based biotechnology company, announced the Department of Defense has awarded the company another $14.5M to accelerate its antibody discovery and optimize for biothreats. According to A-Alpha Bio cofounder and CEO, David Younger, PHD, “We’ve measured 10 million interactions in this collaboration and have focused so far on three pathogenic families. This extension of funding will allow us to really broaden both our potential impact on pandemic preparedness and our interest in training more generalizable models. Having an interaction space that covers more pathogen diversity is exactly what we’re interested in doing.” The post Bud-wiser: DOD Backs A-Alpha Bio for Biothreat Preparation appeared first on Life Science Washington . Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Day one of Biotech Summit Austria is in full swing! We've had the pleasure of meeting with many industry professionals. Let's meet up: book a meeting with us through PartneringOne and Let's discuss the latest trends in biotechnology 👩🔬👨🔬 #BiotechSummitAustria #PharmaLegacy

"Thrilled to be part of organizing the 3rd International Conference on Biotechnology! Honored to welcome esteemed doctors and scientists, pushing boundaries and shaping the future of biotech. Together, let's ignite innovation and pave the way for transformative discoveries! #BiotechConference #Innovation #ScienceLeaders"

Discover the latest trends and innovations shaping the future of biotechnology from #BIO2024! From psychedelics to AI in drug discovery, learn what we saw and heard about how the industry is navigating challenges and driving change.   Read more here: https://bit.ly/3VGD0rJ   #Biotech #HealthcareInnovation #BIO2024Insights #HealthcareComms #InizioEvokeComms

🚀Breaking news!📣 Genomadix proudly unveils one of the first #CubeX Open Platform Partnerships with LuminUltra Technologies Ltd.! Under this partnership, LuminUltra will be developing and commercializing molecular assays for the water, energy and food and beverage industries using the Genomadix Cube qPCR technology using the CubeX Open Platform while also tacking over the #legionella testing business of Genomadix Inc. Steve Edgett, CEO of Genomadix, stated “Genomadix is focused on the development and commercialization of precision medicine tests on the Cube and licensing our CubeX Open Platform to strategic partners. LuminUltra was the perfect home for the legionella business that we had nurtured under the Spartan Bioscience brand. We intend to support a seamless transition with our customers and are thrilled that LuminUltra will bring scale, expertise, and focus to the Legionella business. This agreement is our first CubeX Open Platform strategic partnership. We look forward to more partnerships in other markets in the future.” 🔗 Learn more about the exciting partnership here: https://lnkd.in/egsfVteN #GenomadixCube #LuminUltra #partnership #partnershipannouncement #startups #qpcr #biotechnology #moleculardiagnostics #diagnostics #genotyping #genetictesting #healthcare #precisionmedicine #precisionhealth #microbialmonitoring #publichealth #Pharmacogenetics #Pharmacogenomics #PGx #PGxmovement

Launching a #biotech startup is like igniting a rocket: the initial lift-off is the toughest. But once you're airborne, momentum takes over. 🧬 Take that first daring step and trust LAWIANS LLP to propel your biotech innovations forward. Let us be your trusted patent advisors. Make a 🦁 Lion move in biotechnology sectors with LAWIANS LLP 🦁 #BiotechInnovation #PatentProtection #LawiansLLP #StartupSuccess #Biotech #Nanotechnology #MolecularBiology #Genetics

2023 Year in Review: Biotechnology Developments One way to navigate between the extremes of comprehensiveness and selectiveness is to be representative. This is the course that GEN’s top editors have chosen for this end-of-year review. They have decided to comment, at fair length, on a handful of outstanding presentations from GEN’s State of Biotech 2023, a virtual event that brought together a host of luminaries from industry and academia. https://ow.ly/I5IZ50Qmbo0